| Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery E Roger, F Lagarce, E Garcion, JP Benoit Nanomedicine 5 (2), 287-306, 2010 | 340 | 2010 |
| Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis E Roger, F Lagarce, E Garcion, JP Benoit Journal of controlled release 140 (2), 174-181, 2009 | 281 | 2009 |
| CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer SK Swaminathan, E Roger, U Toti, L Niu, JR Ohlfest, J Panyam Journal of Controlled Release 171 (3), 280-287, 2013 | 207 | 2013 |
| The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting NT Huynh, E Roger, N Lautram, JP Benoît, C Passirani Nanomedicine 5 (9), 1415-1433, 2010 | 201 | 2010 |
| Folic acid functionalized nanoparticles for enhanced oral drug delivery E Roger, S Kalscheuer, A Kirtane, BR Guru, AE Grill, J Whittum-Hudson, ... Molecular pharmaceutics 9 (7), 2103-2110, 2012 | 192 | 2012 |
| Highly lipophilic fluorescent dyes in nano-emulsions: towards bright non-leaking nano-droplets AS Klymchenko, E Roger, N Anton, H Anton, I Shulov, J Vermot, Y Mely, ... RSC advances 2 (31), 11876-11886, 2012 | 170 | 2012 |
| On the benefits of rubbing salt in the cut: Self-healing of saloplastic PAA/PAH compact polyelectrolyte complexes A Reisch, E Roger, T Phoeung, C Antheaume, C Orthlieb, F Boulmedais, ... Adv. Mater 26 (16), 2547-2551, 2014 | 142 | 2014 |
| Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration E Roger, F Lagarce, JP Benoit European journal of pharmaceutics and biopharmaceutics 79 (1), 181-188, 2011 | 140 | 2011 |
| The gastrointestinal stability of lipid nanocapsules E Roger, F Lagarce, JP Benoit International journal of pharmaceutics 379 (2), 260-265, 2009 | 124 | 2009 |
| Models for drug absorption from the small intestine: where are we and where are we going? PA Billat, E Roger, S Faure, F Lagarce Drug discovery today 22 (5), 761-775, 2017 | 122 | 2017 |
| Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel J Hureaux, F Lagarce, F Gagnadoux, L Vecellio, A Clavreul, E Roger, ... European journal of pharmaceutics and biopharmaceutics 73 (2), 239-246, 2009 | 120 | 2009 |
| How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability? H Malhaire, JC Gimel, E Roger, JP Benoît, F Lagarce Advanced drug delivery reviews 106, 320-336, 2016 | 99 | 2016 |
| Compact saloplastic poly (acrylic acid)/poly (allylamine) complexes: Kinetic control over composition, microstructure, and mechanical properties A Reisch, P Tirado, E Roger, F Boulmedais, D Collin, JC Voegel, B Frisch, ... Advanced Functional Materials 23 (6), 673-682, 2013 | 77 | 2013 |
| Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells E Roger, F Lagarce, E Garcion, JP Benoit European Journal of Pharmaceutical Sciences 40 (5), 422-429, 2010 | 72 | 2010 |
| Spontaneous nano-emulsification: Process optimization and modeling for the prediction of the nanoemulsion’s size and polydispersity G Lefebvre, J Riou, G Bastiat, E Roger, K Frombach, JC Gimel, P Saulnier, ... International journal of pharmaceutics 534 (1-2), 220-228, 2017 | 67 | 2017 |
| Advances in treatment formulations for acute myeloid leukemia T Briot, E Roger, S Thépot, F Lagarce Drug discovery today 23 (12), 1936-1949, 2018 | 53 | 2018 |
| Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma A Clavreul, E Roger, M Pourbaghi-Masouleh, L Lemaire, C Tétaud, ... Drug Delivery 25 (1), 1756-1765, 2018 | 48 | 2018 |
| Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model E Roger, JC Gimel, C Bensley, AS Klymchenko, JP Benoit Journal of controlled release 253, 11-18, 2017 | 46 | 2017 |
| Alginate/chitosan compact polyelectrolyte complexes: a cell and bacterial repellent material T Phoeung, MV Spanedda, E Roger, B Heurtault, S Fournel, A Reisch, ... Chemistry of Materials 29 (24), 10418-10425, 2017 | 33 | 2017 |
| Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal? A Clavreul, M Pourbaghi-Masouleh, E Roger, N Lautram, ... Journal of Experimental & Clinical Cancer Research 36, 1-11, 2017 | 31 | 2017 |
